Literature DB >> 8627974

Preventing multidrug-resistant tuberculosis.

A B Bloch, P M Simone, E McCray, K G Castro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627974

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Directly observed therapy and tuberculosis treatment completion. Jereb et al. re: Bayer et al.

Authors:  J A Jereb; P M Simone; I M Onorato
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

2.  Directly observed therapy and tuberculosis treatment completion. Bloch re: Bayer et al.

Authors:  A B Bloch
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

3.  Directly observed therapy for tuberculosis.

Authors:  E Mannino; L Hill
Journal:  West J Med       Date:  1996-10

4.  Evaluation of Etest for susceptibility testing of multidrug-resistant isolates of Mycobacterium tuberculosis.

Authors:  M H Hazbón; M del Socorro Orozco; L A Labrada; R Tovar; K A Weigle; A Wanger
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 5.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

6.  Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family.

Authors:  J L Doran; Y Pang; K E Mdluli; A J Moran; T C Victor; R W Stokes; E Mahenthiralingam; B N Kreiswirth; J L Butt; G S Baron; J D Treit; V J Kerr; P D Van Helden; M C Roberts; F E Nano
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

7.  A global theme issue: bibliography of references.

Authors:  M A Winker
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

Review 8.  The use of platensimycin and platencin to fight antibiotic resistance.

Authors:  Adil M Allahverdiyev; Melahat Bagirova; Emrah Sefik Abamor; Sezen Canim Ates; Rabia Cakir Koc; Meral Miraloglu; Serhat Elcicek; Serkan Yaman; Gokce Unal
Journal:  Infect Drug Resist       Date:  2013-09-18       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.